Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study - Cirak, S; Arechavala-Gomeza, V; Guglieri, M (Lancet, 2011)
, et al.